297 related articles for article (PubMed ID: 6363543)
21. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
Liew FY; Dhaliwal JS
J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
[TBL] [Abstract][Full Text] [Related]
22. Studies on intracellular killing of Leishmania major and lysis of host macrophages by immune lymphoid cells in vitro.
Pham TV; Mauël J
Parasite Immunol; 1987 Nov; 9(6):721-36. PubMed ID: 2448731
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of lymphokine-induced macrophage microbicidal activity against Leishmania major by liposomes: characterization of the physicochemical requirements for liposome inhibition.
Gilbreath MJ; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1986 Sep; 137(5):1681-7. PubMed ID: 3745916
[TBL] [Abstract][Full Text] [Related]
24. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.
Titus RG; Kelso A; Louis JA
Clin Exp Immunol; 1984 Jan; 55(1):157-65. PubMed ID: 6198115
[TBL] [Abstract][Full Text] [Related]
25. Lymphokine mediated microbicidal activity of peritoneal macrophages from Leishmania donovani infected and drug treated BALB/c mice.
Sodhi S; Ganguly NK; Malla N; Mahajan RC
Jpn J Exp Med; 1989 Jun; 59(3):103-8. PubMed ID: 2554031
[TBL] [Abstract][Full Text] [Related]
26. Phagocytosis of Leishmania enhances macrophage activation by IFN-gamma and lipopolysaccharide.
Corradin SB; Mauël J
J Immunol; 1991 Jan; 146(1):279-85. PubMed ID: 1898602
[TBL] [Abstract][Full Text] [Related]
27. Leishmania major and Leishmania tropica: I the in vitro effects of an immunomodulator, S2-Complex.
Al-Mulla Hummadi YM; Najim RA; Al-Bashir NM
Exp Parasitol; 2005 Sep; 111(1):47-54. PubMed ID: 15970286
[TBL] [Abstract][Full Text] [Related]
28. Killing of Leishmania tropica amastigotes by factors in normal human serum.
Hoover DL; Berger M; Nacy CA; Hockmeyer WT; Meltzer MS
J Immunol; 1984 Feb; 132(2):893-7. PubMed ID: 6690622
[TBL] [Abstract][Full Text] [Related]
29. Macrophage activation for antileishmanial defense by an apparently novel mechanism.
Wyler DJ; Beller DI; Sypek JP
J Immunol; 1987 Feb; 138(4):1246-9. PubMed ID: 3100630
[TBL] [Abstract][Full Text] [Related]
30. The role of the macrophage in cutaneous leishmaniasis.
Farah FS; Samra SA; Nuwayri-Salti N
Immunology; 1975 Oct; 29(4):755-64. PubMed ID: 1184120
[TBL] [Abstract][Full Text] [Related]
31. A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages.
Haidaris CG; Bonventre PF
J Immunol; 1982 Aug; 129(2):850-5. PubMed ID: 6282971
[TBL] [Abstract][Full Text] [Related]
32. Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes.
Murray HW
J Immunol; 1982 Jul; 129(1):351-7. PubMed ID: 6282967
[No Abstract] [Full Text] [Related]
33. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
Mosser DM; Edelson PJ
J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
[TBL] [Abstract][Full Text] [Related]
34. Antileishmanial activities of macrophages from C3H/HeN and C3H/HeJ mice treated with Mycobacterium bovis strain BCG.
Pappas MG; Nacy CA
Cell Immunol; 1983 Sep; 80(2):217-22. PubMed ID: 6349826
[TBL] [Abstract][Full Text] [Related]
35. Unveiling pathways used by Leishmania amazonensis amastigotes to subvert macrophage function.
Osorio y Fortéa J; Prina E; de La Llave E; Lecoeur H; Lang T; Milon G
Immunol Rev; 2007 Oct; 219():66-74. PubMed ID: 17850482
[TBL] [Abstract][Full Text] [Related]
36. Differential survival of Leishmania donovani amastigotes in human monocytes.
Pearson RD; Harcus JL; Roberts D; Donowitz GR
J Immunol; 1983 Oct; 131(4):1994-9. PubMed ID: 6619546
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages.
Bogdan C; Streck H; Röllinghoff M; Solbach W
Clin Exp Immunol; 1989 Jan; 75(1):141-6. PubMed ID: 2702771
[TBL] [Abstract][Full Text] [Related]
38. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages.
Channon JY; Roberts MB; Blackwell JM
Immunology; 1984 Oct; 53(2):345-55. PubMed ID: 6490087
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporin A-mediated killing of Leishmania major by macrophages is independent of reactive nitrogen and endogenous TNF-alpha and is not inhibited by IL-10 and 13.
Meissner U; Jüttner S; Röllinghoff M; Gessner A
Parasitol Res; 2003 Feb; 89(3):221-7. PubMed ID: 12541065
[TBL] [Abstract][Full Text] [Related]
40. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
Sypek JP; Panosian CB; Wyler DJ
J Immunol; 1984 Dec; 133(6):3351-7. PubMed ID: 6333458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
